Pfizer advances once-daily version of weight loss pill



Pfizer Inc. announced on Thursday that it will advance the development of the once-daily version of a weight loss pill, dangulipron, after research showed “encouraging” results. “Obesity is a key ther…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento